Effect of dopamine on intracellular sodium: A common pathway for pharmacological mechanism of action in bipolar illness

References

• Adir Y, Azzam ZS, Lecuona E, Leal S, Pesce L, Dumasius V, et al. Augmentation of endogenous dopamine production increases lung liquid clearance. Am J Respir Care Med 2004; 169: 757–763
   PubMedGoogle Scholar
• Aizman O, Brismar H, Uhlen P, Zettergren E, Levey AI, Forssberg H, et al. Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nat Neurosci 2002; 3: 226–230
   Google Scholar
• Ashgar M, Hussain T, Lokhandwala MF. Activation of dopamine D1-like receptor causes phosphorylation of alpha1-subunit of Na,K-ATPase in rat renal proximal tubules. Eur J Pharmacol 2001; 411: 62–66
   Google Scholar
• Astrup J, Sorensen P, Sorensen H. Oxygen and glucose consumption related to Na+-K+ transport in canine brain. Stroke 1981; 12: 726–730
   PubMed Web of Science ®Google Scholar
• Bearden, CE, Thompson, PM, Dalwani, M, Hayashi, KM, Lee, AD, Nicoletti, M, , et al. 2007. Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry, [Epub ahead of print]
   Google Scholar
• Brismar H, Asghar M, Carey RM, Greengard P, Aperia A. Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane. Proc Natl Acad Sci USA 1998; 95: 5573–5578
   PubMed Web of Science ®Google Scholar
• Buchsbaum MS, Wu J, DeLisi LE, Holcomb H, Kessler R, Johnson J, et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord 1986; 10: 137–152
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Keck PE, Jr, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005; 162: 1351–1360
   PubMed Web of Science ®Google Scholar
• Chang A, Li PP, Warsh JJ. Altered cAMP-dependent protein kinase subunit immunolabeling in post-mortem brain from patients with bipolar affective disorder. J Neurochem 2003a; 84: 781–791
   PubMedGoogle Scholar
• Chang A, Li PP, Warsh JJ. cAMP-Dependent protein kinase (PKA) subunit mRNA levels in postmortem brain from patients with bipolar affective disorder (BD). Brain Res Mol Brain Res 2003b; 116: 27–37
   PubMedGoogle Scholar
• Coppen A, Shaw DM, Malleson A, Costain R. Mineral metabolism in mania. Br Med J 1966; 1: 71–75
   PubMed Web of Science ®Google Scholar
• Dubovsky SL, Franks RD. Intracellular ions in affective disorders: A review and an hypothesis. Biol Psychiatry 1983; 18: 781–797
   PubMed Web of Science ®Google Scholar
• Dubovsky SL, Christiano J, Daniell LC, Franks RD, Murphy J, Adler L, et al. Increased platelet intracellular calcium concentrations in patients with bipolar affective disorders. Arch Gen Psychiatry 1989; 46: 632–638
   PubMed Web of Science ®Google Scholar
• Dubovsky SL, Lee C, Christiano J, Murphy J. Lithium decreases platelet intracellular calcium concentration in bipolar patients. Lithium 1991; 2: 167–174
   Google Scholar
• Dubovsky SL, Murphy J, Thomas M, Rademacher J. Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am J Psychiatry 1992; 149: 118–120
   PubMed Web of Science ®Google Scholar
• Dubovsky SL, Thomas M, Hijazi A, Murphy J. Intracellular calcium signaling in peripheral cells of patients with bipolar affective disorder. Eur Arch Psychiatry Clin Neurosci 1994; 243: 229–234
   PubMed Web of Science ®Google Scholar
• El-Mallakh RS, Huff MO. Mood stabilizers and ion regulation. Harv Rev Psychiatry 2001; 9: 23–32
   PubMed Web of Science ®Google Scholar
• El-Mallakh RS, Wyatt RJ. The Na,K-ATPase hypothesis for bipolar illness. Biol Psychiatry 1995; 37: 235–244
   PubMed Web of Science ®Google Scholar
• El-Mallakh RS, Harrison LT, Li R, Changaris DG, Levy RS. An animal model for mania: Preliminary results. Prog Neuro-Psychopharmacol Biol Psychiatry 1995; 19: 955–962
   PubMed Web of Science ®Google Scholar
• El-Mallakh RS, El-Masri MA, Huff MO, Li X-P, Decker S, Levy RS. Intracerebroventricular administration of ouabain to rats models human mania. Bipolar Disord 2003; 5: 362–365
   PubMedGoogle Scholar
• El-Mallakh RS, Decker S, Morris M, Li Z-P, Huff MO, El-Masri MA, et al. The effect of olanzapine and haloperidol in an animal's model of mania. Prog Neuro-Psychopharmacol Biol Psychiatry 2006a; 30: 1261–1264
   PubMedGoogle Scholar
• El-Mallakh, RS (December, 2006) Stoddard, M, Jortani, SA, El-Masri, MA, Sephton, S, Valdes, R, Jr. 2006b. Aberrant regulation of endogenous ouabain-like factor in bipolar subjects. Presented at the annual Meeting of the American College of NeuropsychopharmacologyMiami, FL
   Google Scholar
• Else PL, Mansfield K. Activation of sodium transport and intracellular sodium lowering by the neuroleptic drug chlorpromazine. Biochem Pharmacol 1997; 54: 275–281
   PubMedGoogle Scholar
• Emamghoreishi M, Schlichter L, Li PP, Parikh S, Sen J, Kamble A, Warsh JJ. High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. Am J Psychiatry 1997; 154: 976–982
   PubMed Web of Science ®Google Scholar
• Fan S, Yazulla S. Reciprocal inhibition of voltage-gated potassium currents (IK(V)) by activation of cannabinoid CB1 and dopamine D1 receptors in ON bipolar cells of goldfish retina. Visual Neurosci 2005; 22: 55–63
   PubMedGoogle Scholar
• Ferreira MP, DeLucia R, Aizenstein ML, Glezer AI, Scavone C. Fencamfamine modulates sodium, potassium-ATPase through cyclic AMP and cyclic AMP-dependent protein kinase in rat striatum. J Neural Transm 1998; 105: 549–560
   PubMedGoogle Scholar
• Gao, YL (June, 2007) Lei, Z, Roisen, F, Lu, C, El-Mallakh, RS. 2007. Effect of monensin and intracellular sodium concentration elevation of the bipolar candidate gene transient receptor potential protein melastatin subtype 2 (TRMP2). Presented at the 7th International Bipolar MeetingPittsburgh, PA
   Google Scholar
• Gefvert O, Bergstrom M, Laangstroem B, Lundberg T, Lindstrom L, Yates R. Time course of central nervous dopamine-D2 and 5HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine in patients with schizophrenia. Psychopharmacology 1998; 135: 119–126
   PubMed Web of Science ®Google Scholar
• Gomes P, Soares-da-Silva P. D2-like receptor medicated inhibition of Na+-K+-ATPase activity is dependent on the opening of K+ channels. Am J Physiol Renal Physiol 2002; 382: F114–F123
   Google Scholar
• Gomes P, Soares-da-Silva P. Dopamine acutely decreases type 3 Na(+)/H(+) exchanges activity in renal OK cells through the activation of protein kinases A and C signaling cascades. Eur J Pharmacol 2004; 488: 51–59
   PubMedGoogle Scholar
• Goodwin FK, Jamison KR. Manic depressive illness. Oxford University Press, New York, Oxford 1990
   Google Scholar
• Grider G, El-Mallakh RS, Huff MO, Buss TJR, Miller J, Valdes R, Jr. Endogenous digoxin-like immunoreactive factor (DLIF) serum concentrations are decreased in manic bipolar patients compared to normal controls. J Affect Disord 1999; 54: 261–267
   PubMedGoogle Scholar
• Guatteo E, Bengtson CP, Bernardi G, Mercuri NB. Voltage-gated calcium channels mediate intracellular calcium increase in weaver dopaminergic neurons during stimulation of D2 and GABAB receptors. J Neurophysiol 2004; 92: 3368–3374
   PubMedGoogle Scholar
• Hu XT, Dong Y, Zhang XF, White FJ. Dopamine D2 receptor-activated Ca2 + signaling modulates voltage-sensitive sodium currents in rat nucleus accumbens neurons. J Neurophysiol 2005; 93: 1406–1417
   PubMedGoogle Scholar
• Hua LV, Green M, Wong A, Warsh JJ, Li PP. Tetraspan protein CD151: a common target of mood stabilizing drugs?. Neuropsychopharmacology 2001; 25: 729–736
   PubMedGoogle Scholar
• Huang X, Lei Z, El-Mallakh RS. Lithium normalizes elevated intracellular sodium. Bipolar Disord 2007; 9(3)298–300
   PubMedGoogle Scholar
• Jose PA, Eisner GM, Felder RA. Renal dopamine and sodium homeostasis. Curr Hypertens Rep 2000; 2: 174–183
   PubMedGoogle Scholar
• Kim HS, Yumkham S, Choi JH, Kim E-K, Kim YS, Ryu SH, et al. Haloperidol induces calcium ion influx via L-type calcium channels in hippocampal HN33 cells and renders the neurons more susceptible to oxidative stress. Mol Cells 2006; 22: 51–57
   PubMedGoogle Scholar
• LaHoste GJ, Henry BL, Marshall JF. Dopamine D1 recptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials. J Neurosci 2000; 20: 6666–6671
   PubMed Web of Science ®Google Scholar
• Li R, El-Mallakh RS. Differential response of bipolar and normal control lymphoblastoid cell sodium pump to ethacrynic acid. J Affect Disord 2004; 80: 11–17
   PubMed Web of Science ®Google Scholar
• Looney SW, El-Mallakh RS. Meta-analysis of erythrocyte Na,K-ATPase activity in bipolar illness. Depress Anxiety 1997; 5: 53–65
   PubMedGoogle Scholar
• Mah L, Zarate CA, Jr, Singh J, Duan YF, Luckenbaugh DA, Manji HK, et al. Regional cerebral glucose metabolic abnormalities in bipolar II depression. Biol Psychiatry 2007; 61: 765–775
   PubMed Web of Science ®Google Scholar
• Manji HK, Chen G. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers. Mol Psychiatry 2002; 7(Suppl 1)S46–56
   PubMedGoogle Scholar
• Manji HK, Lenox RH. Signaling: cellular insights into the pathophysiology of bipolar disorder. Biol Psychiatry 2000; 48: 518–530
   PubMed Web of Science ®Google Scholar
• Manji HK, Moore GJ, Chen G. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers. Br J Psychiatry 2001; 41(Suppl)S107–119
   Google Scholar
• Manji HK, Quiroz JA, Payne JL, Singh J, Lopes BP, Viegas JS, et al. The underlying neurobiology of bipolar disorder. World Psychiatry 2003; 2: 136–146
   PubMedGoogle Scholar
• Mazumder G, Mukherjee S, Sen PC. The chlorpromazine inhibition of transport ATPase and acetylcholinesterase activities in the microsomal membranes of rat in vitro and in vivo. Mol Cell Biochem 1990; 95: 13–20
   PubMed Web of Science ®Google Scholar
• Naylor GJ, Smith AHW. Defective genetic control of sodium-pump density in manic depressive psychosis. Psychol Med 1981; 11: 257–263
   PubMed Web of Science ®Google Scholar
• Naylor GJ, McNamee HB, Moody JP. Changes in erythrocyte sodium and potassium on recovery from depressive illness. Br J Psychiatry 1971; 118: 219–223
   PubMedGoogle Scholar
• Ogata N, Yoshii M, Narahashi T. Differential block of sodium and calcium channels by chlorpromazine in mouse neuroblastoma cells. J Physiol 1990; 420: 165–183
   PubMedGoogle Scholar
• Ordieres MGL, de Lores Arnaiz GR. The inhibitory effect of neurotensin on synaptosomal membrane Na,K-ATPase is altered by antipsychotic administration. Regul Peptides 2005; 129: 177–182
   PubMedGoogle Scholar
• Palotas A, Penke B, Palotas M, Kenderessy AS, Kemeny L, Kis E, et al. Haloperidol attenuates beta-amyloid-induced calcium imbalance in human fibroblasts. Skin Pharmacol Physiol 2004; 17: 195–199
   PubMedGoogle Scholar
• Piper, DC, Cooper, DA, Upton, N. 1996. The effect of antimanic drugs on the hyperlocomotor response to ICV administration of ouabain in the rat. Presented at the Annual Meeting of the European College of NeuropsychopharmacologyAmsterdamThe Netherlands
   Google Scholar
• Prokopenko RA, Mogilevich SE, Luik AI, Naydyenova IY, Batrak GN, Hawryluk BR, et al. Effects of haloperidol and chlorpromazine on smooth muscle contractility, platelet aggregation and neuronal calcium current. Gen Physiol Biophys 1995; 14: 349–357
   PubMedGoogle Scholar
• Robbins TW, Sahakian BJ. Animal Models of mania. Mania: An evolving concept, RH. Bellmaker, HM Ban Prang. Spectrum, New York 1980; 143–216
   Google Scholar
• Rose AM, Mellett BJ, Valdes R, Jr, Kleinman JE, Hermann MM, Li R, El-Mallakh RS. Alpha2 isoform of the Na,K-ATPase is reduced in temporal cortex of bipolar individuals. Biol Psychiatry 1998; 44: 892–897
   PubMed Web of Science ®Google Scholar
• Rosso IM, Killgore WD, Clintron CM, Gruber SA, Tohen M, Yurgelun-Todd DA. Reduced amygdala volumes in first-episode bipolar disorder and correlation with cerebral white matter. Biol Psychiatry 2007; 61: 743–749
   PubMed Web of Science ®Google Scholar
• Ruktanonchai DJ, El-Mallakh RS, Li R, Levy RS. Persistent hyperactivity following a single intracerebroventricular dose of ouabain. Physiol Behav 1998; 63: 403–406
   PubMed Web of Science ®Google Scholar
• Sah DW, Bean BP. Inhibition of P-type and N-type calcium channels by dopamine receptor antagonists. Mol Pharmacol 1994; 45: 84–92
   PubMed Web of Science ®Google Scholar
• Santi CM, Cayabyab FS, Sutton KG, McRory JE, Mezeyova J, Manning KS, et al. Differential inhibition of T-type calcium channels by neuroleptics. J Neurosci 2002; 15: 396–403
   Google Scholar
• Shaw DM. Mineral metabolism, mania, and melancholia. Br Med J 1966; 2: 262–267
   PubMed Web of Science ®Google Scholar
• Shulman LM, Fox DA. Dopamine inhibits mammalian photoreceptor Na,K-ATPase activity via a selective effect on the alpha-3 isozyme. Proc Natl Acad Sci USA 1996; 93: 8034–8039
   PubMedGoogle Scholar
• Sun W, Salvi RJ. Dopamine modulates sodium currents in cochlear spiral ganglion neurons. Neuroreport 2001; 12: 803–807
   PubMedGoogle Scholar
• Surja AAS, Tamas RL, El-Mallakh RS. Antipsychotic medications in the treatment of bipolar disorder. Curr Drug Targets 2006; 7: 1217–1224
   PubMed Web of Science ®Google Scholar
• Tan CH, Javors MA, Seleshi E, Lowrimore PA, Bowden CL. Effects of lithium on platelet ionic intracellular calcium concentration in patients with bipolar (manic-depressive) disorder and healthy controls. Life Sci 1990; 46: 1175–1180
   PubMedGoogle Scholar
• Thase, ME, Macfadden, W, McCoy, W, Chang, W, Calabrese, JR. 2006. Confirmation of the efficacy of quetiapine monotherapy in bipolar depression in a second double-blind, placebo-controlled study: the BOLDER II study, Presented at the American Psychiatric Association meeting, Toronto, Canada, May 2006, J Clin Psychopharmacol, 26: 600–609. (Erratum: J Clin Psychopharmacol 2007, 27:51)
   PubMed Web of Science ®Google Scholar
• Thiruvengadam, AP, Chandrasekaran, K, Regenold, WT. 2007. Diagnostic blood test for bipolar disorder. J Affect Disord, (Epub ahead of print)
   PubMedGoogle Scholar
• Ueda K, Yagami T, Asakura K, Kawasaki K. Chlorpromazine reduces toxicity and Ca2 + uptake induced by amyloid beta protein (25–35) in vitro. Brain Res 1997; 748: 184–188
   PubMedGoogle Scholar
• Van Dyke RW, Scharschmidt BF. Effects of chlorpromazine on Na,K-ATPase pumping and solute transport in rat hepatocytes. Am J Physiol 1987; 253: G613–621
   Google Scholar
• Vieira-Coelho MA, Soares-da-Silva P. Comparative study on sodium transport and Na+,K + -ATPase activity in Caco-2 and rat jejunal epithelial cells: Effects of dopamine. Life Sci 1981; 69: 1969–1981
   Google Scholar
• Wakamori M, Kaneda M, Oyama Y, Akaike N. Effects of chlordiazepoxide, chlorpromazine, diazepam, diphenylhydantoin, flunitrazepam, and haloperidol on the voltage-dependent sodium current of isolated mammalian brain neurons. Brain Res 1989; 494: 374–378
   PubMedGoogle Scholar
• Wasserman MJ, Corson TW, Sibony D, Cooke RG, Parikh SV, Pennefather PS, et al. Chronic lithium treatment attenuates intracellular calcium mobilization. Neuropsychopharmacology 2004; 29: 759–769
   PubMed Web of Science ®Google Scholar
• Wood AJ, Smith CE, Clarke EE, Cowen PJ, Aronson JK, Grahame-Smith DG. Altered in vitro adaptive responses of lymphocyte Na+,K+-ATPase in patients with manic-depressive psychosis. J Affect Disord 1991; 21: 199–206
   PubMed Web of Science ®Google Scholar
• Wu J, Dougherty JJ, Nichols RA. Dopamine receptor regulation of Ca2 + levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors. J Neurochem 2006; 98: 481–494
   PubMedGoogle Scholar
• Yamaguchi I, Walk SF, Jose PA, Felder RA. Dopamine D2L receptors stimulate Na,K-ATPase activity in murine LTK- cells. Mol Pharmacol 1996; 49: 376–378
   Google Scholar
• Yoon IS, Li PP, Siu KP, Kennedy JL, Cooke RG, Parikh SV, Warsh JJ. Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder. Mol Psychiatry 2001a; 6: 678–83
   PubMedGoogle Scholar
• Yoon IS, Li PP, Siu KP, Kennedy JL, Macciardi F, Cooke RG, et al. Altered TRPC7 gene expression in bipolar-I disorder. Biol Psychiatry 2001b; 50: 620–626
   PubMedGoogle Scholar
• Xu C, Macciardi F, Li PP, Yoon IS, Cooke RG, Hughes B, et al. Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2006; 50: 620–626
   Google Scholar